Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Kaufen / Verkaufen

Top-Partner CFD-Broker

Plus500
  • Keine Kommissionen, enge Spreads
  • Hebel- und Long/Short-Trading, fortgeschrittene Analysetools, kostenlose Echtzeitkurse etc.
  • CFD-Trading auf Aktien, Indizes, Krypto, Rohstoffe und Devisen
Direkt zu Plus500 CFD service. Ihr Kapital unterliegt einem Risiko.

Premium-Partner

IG Bank
  • Ein weltweit führender CFD-Anbieter*, FINMA-reguliert
  • Über 17'000 Märkte: Indizes, Devisen, Rohstoffe, Aktien, Kryptowährungen, Optionen und mehr
  • Erweiterte Handelszeiten und Wochenendhandel
  • Schweizer Kundenserviceteam, mit Büros in Genf und Zürich
*Die IG Gruppe ist grösster Anbieter nach Umsatz (veröffentlichter Geschäftsbericht 2022)
Direkt zur IG Bank Verluste können Einlagen übersteigen.
Saxo Bank
  • Lizenzierte Schweizer Bank (FINMA)
  • Keine Depotgebühren bei aktivierter Wertpapierleihe
  • Aktien, ETFs, Optionen, FX, CFDs, Futures, Rohstoffe, Bonds, Mutual Funds - auf einer Plattform
  • Gratis Expertenanalysen und Trading-Signale
  • Saxo Deal: Rückerstattung der Courtagen bis CHF 200 während 90 Tagen
Direkt zur Saxo Bank
Werbung
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
26.11.2024 21:29:52

H2APEX adjusts its revenue forecast for 2024 due to timing shifts in revenue recognition. Nevertheless, H2APEX aims for nearly a doubling of revenue compared to the previous year.

exceet Group
4.90 EUR -2.97%
Kaufen / Verkaufen


EQS-Media / 26.11.2024 / 21:29 CET/CEST

H2APEX adjusts its revenue forecast for 2024 due to timing shifts in revenue recognition. Nevertheless, H2APEX aims for nearly a doubling of revenue compared to the previous year.

  • Revenue forecast for 2024 has been specified at a minimum of EUR 28 million.
  • Especially delays in deliveries have been a key factor leading to the shift in revenues.
  • Revenues not realized in 2024 will be recognized with a slight delay in 2025.

Grevenmacher (Luxembourg), November 26, 2024 – H2APEX (ISIN LU0472835155, WKN A0YF5P, formerly exceet Group SCA), a publicly listed leading developer and operator of green hydrogen plants for the decarbonization of industry, infrastructure, and mobility, announced today that it has adjusted its revenue forecast for the fiscal year 2024 as communicated in the group annual report 2023 based on recent developments. H2APEX now expects revenue of at least EUR 28 million for fiscal year 2024, compared to the previously projected range of EUR 35–40 million outlined in its 2023 group business report.

H2APEX still expects the total revenue volume to align with the original forecast based on its order backlog. However, the revenues are now expected to be distributed over a longer period. As a result, it is anticipated that not all revenues will be booked in the 2024 fiscal year as initially assumed. In particular, delays in component deliveries for projects have extended project timelines, meaning the deferred revenue will now be recognized in 2025.

Peter Rößner, CEO of H2APEX Group’s operations, stated: “The delays in revenue recognition are primarily due to delivery delays of components. We are doing everything possible to satisfy our customers and are optimistic that we can now move forward quickly to complete the projects – including one of the largest hydrogen electrolyzers in Germany with a capacity of 10 MW. Ensuring proper handover and reliable operation remains our top priority.”

Bert Althaus, CFO of H2APEX Group, added: “We will have nearly doubled our revenue in fiscal year 2024 compared to the previous year. Delays in revenue are the reason, why growth has not been even stronger. The deferred revenues will now contribute to our success in 2025. We will continue to structurally and with regards to personell align  our organization to growth strategy and we will continue working to align our organizational structure and personnel with our growth objectives.”

The ad hoc announcement regarding the 2024 revenue forecast is available for download in the "Investor Relations" section of the company website at www.h2apex.com. The interim report for the first three quarters of fiscal year 2024 will also be available there starting November 28, 2024.

About H2APEX

H2APEX is a merger of the H2APEX Group SCA (ISIN LU0472835155, WKN A0YF5P), listed in the Prime Standard of the Frankfurt Stock Exchange, and hydrogen specialist APEX Group. Together, the companies act in the market under the H2APEX brand. The operational core of H2APEX was founded in 2000 in Rostock/Laage and has focused entirely on clean hydrogen production, storage, and distribution since 2012. This makes the company one of the pioneers in this field. The goal of H2APEX is to become an internationally established developer and operator of hydrogen plants. In its core business, H2APEX develops, builds and  sells or operates green hydrogen plants with an electrolysis capacity of less than 1 GW. These are used to decarbonize industrial value chains and produce green hydrogen and hydrogen derivatives such as LOHC (liquid organic hydrogen carriers) and e-fuels. They are used for example in the steel, chemicals and cement industries as well as other energy-intensive industries. In addition the company offers plants for infrastructure and logistics, especially for industrial use in warehouses, ports, and production facilities.

www.h2apex.com

Investor contact:
Phone: +49 381 799902 320
E-Mail: investor.relations@h2apex.com

Web: www.ir.h2apex.com

Press contact:
Kirsten Brückner
Phone: +49 381 799902 347
E-Mail: presse@apex-energy.de



End of Media Release


Issuer: H2APEX Group SCA
Key word(s): Energy

26.11.2024 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: H2APEX Group SCA
19, rue de Flaxweiler
6776 Grevenmacher
Luxemburg
Phone: +352 2838 4720
Fax: +352 2838 4729
E-mail: info@exceet.com
Internet: www.h2apex.com
ISIN: LU0472835155, LU0472839819
WKN: A0YF5P, A1BFHT
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2038839

 
End of News EQS Media

2038839  26.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2038839&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu exceet Group SE

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mut zum Risiko – BX Morningcall mit Dr. Ralf Seiz & François Bloch

🔔🔔🔔 Im heutigen BX Morningcall Spezial gibt Dr. Ralf Seiz, CEO und Gründer der Finreon AG, spannende Einblicke in innovative Anlagelösungen. Als Spin-off der Universität St. Gallen bietet Finreon Strategien an, die Diversifikation und Risikomanagement vereinen – unter anderem durch die systematische Reduktion von Aktienkonzentrationen und die Nutzung von Volatilitätsprämien.

Zusammen mit dem Investmentstrategen François Bloch und Olivia Hähnel von BX Swiss spricht der promovierte Ökonom auch über die aktuellen wirtschaftlichen Herausforderungen und gibt exklusive Einblicke in seine persönlichen Anlageprojekte.

👉🏽 https://bxplus.ch/bx-musterportfolio/

Mut zum Risiko – BX Morningcall mit Dr. Ralf Seiz & François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’136.59 19.95 BCASMU
Short 12’415.14 13.73 UBS07U
Short 12’860.91 8.98 UMBS6U
SMI-Kurs: 11’681.87 11.12.2024 17:31:29
Long 11’178.23 18.82 SSRM9U
Long 10’943.12 13.73 SSQMQU
Long 10’481.71 8.94 SS5M5U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten